In the available literature, studies evaluating the relationship between plasma concentrations of OPG and IL-1RL1 (sST2) are lacking; this applies to both the general population and the population of CKD patients, including those on renal replacement therapy. Here, TNFRSF11B is linked to chronic kidney disease.